SIS Shulov Innovative Science

SIS Shulov Innovative Science Overview

Shulov Innovative Science (SIS) is an advanced clinical-stage biopharmaceutical company focusing on developing New Chemical Entities (NCE’s) for a variety of therapeutic uses. The NCE’s are short synthetic peptides with a unique pharmacological activity of combined potency as an effective anti-inflammatory, anti-viral, and analgesic agent. The NCE’s under development are short synthetic peptides branded as ZEP-3 and ZEP-4, and both molecules possess the unique biological activity and potent therapeutic use for a wide range of clinical indications. The company completed a Phase II clinical study in Herpes Labialis (Cold sores) and has approached the FDA in preparation for a pre-IND meeting to secure an IND submission for an advanced Phase III clinical trial in Herpes Labialis patients in the US. It is the next step towards regulatory approval for the marketing and commercialization of its lead compound. In addition, SIS conducts a Phase II clinical study in Atopic Dermatitis (AD), a common and underserved dermatological disorder, in 9 clinical sites at the leading dermatology departments at hospitals and community clinics in Israel. SIS is developing additional clinical indications such as Herpes Zoster, Genital Herpes, Burns, and Lung Inflammation. Pre-clinical work is complete, and the company is ready to start a Phase I/II study on each of these indications.

Latest News

Mar 28, 2006 · www.dailymail.co.uk

growth-positive

Snake venom could relieve arthritis

Scientists at the Shulov Institute of Sciences (SIS) in Israel claim that snake venom could potentially ease the pain of arthritis and cancer. They have isolated a molecule from the venom that has analgesic properties and created a synthetic copy called VeP-3. A snake venom pain-relieving cream could be available for sale within five years. The Arthritis Research Campaign has heard of cases where people with arthritis experienced pain reduction after being bitten by snakes or stung by bees or nettles. However, seeking out venomous creatures is not recommended, and a synthetic form of venom without toxins may be a safer solution.

Customers

Funding

Team Members

4

Employees: 11-50

Web & Social Links

Locations

Prof. Hillel ve-Khanan Oppenheimer Street 10, Rehovot, Israel

Photos & Videos

No files yet

SIS Shulov Innovative Science Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info